First Subject Dosed in RDC5 Clinical Study

Chronos’ first clinical study commenced on 17th December. The study compares two delivery routes for lead compound RDC5 and is expected to complete in Q1 2014.

Contact Us

Want to get in touch? Send us an email.

Not readable? Change text. captcha txt